Roche Holding AG (WBO:ROGH) Net Interest Margin (Bank Only) %


WBO:ROGH Roche Holding AG WBO:ROGH
52 GF Score
Price €367.40
GF Value €295.69
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

WBO:ROGH
52GF Score
Roche Holding AG WBO:ROGH
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (WBO:ROGH) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of €367.40 is trading 24.3% above its estimated GF Value™ of €295.69. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for WBO:ROGH:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €295.69 vs. price of €367.40 (24.3% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the WBO:ROGH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
52GF Score

Get the complete analysis for WBO:ROGH

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€367.40
Price
€295.69
GF Value